• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    China IUCD Market

    ID: MRFR/MED/0798-HCR
    80 Pages
    Rahul Gotadki
    September 2025

    China IUCD Market Research Report Information, by type (Hormonal IUD, Copper IUD and others), by end users (Hospitals, Clinics and others) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    China IUCD Market Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    China IUCD Market Summary

    The Global China IUCD Market is projected to grow from 2500 USD Million in 2024 to 5000 USD Million by 2035.

    Key Market Trends & Highlights

    China IUCD Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 6.5 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 5000 USD Million, indicating robust growth potential.
    • In 2024, the market is valued at 2500 USD Million, reflecting a strong foundation for future expansion.
    • Growing adoption of IUCDs due to increased awareness of family planning is a major market driver.

    Market Size & Forecast

    2024 Market Size 2500 (USD Million)
    2035 Market Size 5000 (USD Million)
    CAGR (2025 - 2035) 6.5%

    Major Players

    Apple Inc (US), Microsoft Corp (US), Amazon.com Inc (US), Alphabet Inc (US), Berkshire Hathaway Inc (US), Tesla Inc (US), Meta Platforms Inc (US), Johnson & Johnson (US), Visa Inc (US), Procter & Gamble Co (US)

    China IUCD Market Drivers

    Government Initiatives and Policies

    Government initiatives play a crucial role in shaping the Global China IUCD Market Industry. The Chinese government has implemented various policies aimed at enhancing reproductive health services and access to contraceptives. These initiatives include educational campaigns and subsidized healthcare services, which aim to increase the adoption of IUCDs among women. As a result, the market is projected to grow significantly, with estimates suggesting a value of 5000 USD Million by 2035. Such policies not only promote the use of IUCDs but also contribute to a broader understanding of family planning, thereby fostering a supportive environment for market growth.

    Growing Awareness of Health Benefits

    There is a growing awareness of the health benefits associated with IUCDs, which significantly influences the Global China IUCD Market Industry. Women are increasingly recognizing that IUCDs not only provide effective contraception but also offer additional health advantages, such as reduced menstrual bleeding and lower risk of certain reproductive health issues. This awareness is bolstered by healthcare providers who advocate for IUCDs as a viable option for long-term family planning. As more women become informed about these benefits, the demand for IUCDs is expected to rise, contributing to the overall growth of the market and enhancing its value in the coming years.

    Increased Access to Healthcare Services

    Increased access to healthcare services is a pivotal driver for the Global China IUCD Market Industry. The expansion of healthcare infrastructure in urban and rural areas facilitates greater availability of reproductive health services, including IUCD insertion and follow-up care. This improved access is likely to encourage more women to consider IUCDs as a contraceptive option. Furthermore, partnerships between government and non-governmental organizations aim to enhance service delivery, ensuring that women receive adequate information and support. As access to these services improves, the market is poised for growth, aligning with the projected increase in market value and adoption rates.

    Market Growth Projections (Charts Only)

    Rising Demand for Contraceptive Solutions

    The Global China IUCD Market Industry experiences a notable surge in demand for effective contraceptive solutions. This trend is driven by increasing awareness of family planning and reproductive health among women. As of 2024, the market is valued at approximately 2500 USD Million, reflecting a growing preference for long-term contraceptive methods. The Chinese government actively promotes reproductive health initiatives, which further supports this demand. Moreover, the rising number of women in reproductive age contributes to the expansion of the market, as more individuals seek reliable and reversible contraceptive options. This growing awareness and demand are likely to propel the market forward.

    Technological Advancements in IUCD Design

    Technological advancements in IUCD design are transforming the Global China IUCD Market Industry. Innovations such as the development of smaller, more comfortable devices and the introduction of hormone-releasing IUCDs enhance user experience and efficacy. These advancements are likely to attract a larger segment of the population, as they address common concerns related to discomfort and side effects. The continuous improvement in IUCD technology may lead to increased adoption rates, further driving market growth. As the industry evolves, it is expected that these innovations will contribute to a compound annual growth rate of 6.5% from 2025 to 2035, reflecting a robust market trajectory.

    Key Companies in the China IUCD Market market include

    Future Outlook

    China IUCD Market Future Outlook

    The China IUCD Market is projected to grow at a 6.5% CAGR from 2024 to 2035, driven by increasing awareness of reproductive health and government initiatives.

    New opportunities lie in:

    • Develop advanced IUCDs with drug delivery systems to enhance efficacy.
    • Expand distribution networks in rural areas to increase accessibility.
    • Leverage digital platforms for education and awareness campaigns on IUCD benefits.

    By 2035, the China IUCD Market is expected to achieve substantial growth, reflecting evolving consumer needs and enhanced healthcare policies.

    Market Segmentation

     

    • SMB Corporation Of India
    • Bayer HealthCare Pharmaceuticals Inc. (US) 
    • Mona Lisa (Belgium)
    • Teva Women’s Health 
    • DKT International (US)

    May 2023:

    • Main objective of this research is to provide information about IUCD market, types of provider services and payer services.
    • To provide detailed analysis of the market structure along with forecast for the next seven years of the various segments and sub-segments of the IUCD market.
    • To provide insights about factors affecting the market growth.
    • To analyze the IUCD based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
    • To provide historical and forecast revenue of the China IUCD Market segments and sub-segments with respect to China
    • To provide country level analysis of the China IUCD Market with respect to the current market size and future prospective.
    • To provide country level analysis of the China IUCD Market for segments by diagnosis and by end users and its sub-segments.
    • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.
    • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the China IUCD market. 
    • SMB Corporation Of India
    • Bayer HealthCare Pharmaceuticals Inc. (US) 
    • Mona Lisa (Belgium)
    • Teva Women’s Health 
    • DKT International (US)

    Key Players

    • SMB Corporation Of India
    • Bayer HealthCare Pharmaceuticals Inc. (US) 
    • Mona Lisa (Belgium)
    • Teva Women’s Health 
    • DKT International (US)

    China IUCD Market

    • SMB Corporation Of India
    • Bayer HealthCare Pharmaceuticals Inc. (US) 
    • Mona Lisa (Belgium)
    • Teva Women’s Health 
    • DKT International (US)

    Intended Audience

    • Healthcare IT companies
    • Healthcare companies
    • Contract Research Organizations (CROs)
    • Research and Development (R&D) Companies
    • Academic Medical Institutes and Universities

    Study objectives:

    • Main objective of this research is to provide information about IUCD market, types of provider services and payer services.
    • To provide detailed analysis of the market structure along with forecast for the next seven years of the various segments and sub-segments of the IUCD market.
    • To provide insights about factors affecting the market growth.
    • To analyze the IUCD based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
    • To provide historical and forecast revenue of the China IUCD Market segments and sub-segments with respect to China
    • To provide country level analysis of the China IUCD Market with respect to the current market size and future prospective.
    • To provide country level analysis of the China IUCD Market for segments by diagnosis and by end users and its sub-segments.
    • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.
    • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the China IUCD market. 
    • SMB Corporation Of India
    • Bayer HealthCare Pharmaceuticals Inc. (US) 
    • Mona Lisa (Belgium)
    • Teva Women’s Health 
    • DKT International (US)

    China IUCD Market Overview

    • Main objective of this research is to provide information about IUCD market, types of provider services and payer services.
    • To provide detailed analysis of the market structure along with forecast for the next seven years of the various segments and sub-segments of the IUCD market.
    • To provide insights about factors affecting the market growth.
    • To analyze the IUCD based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
    • To provide historical and forecast revenue of the China IUCD Market segments and sub-segments with respect to China
    • To provide country level analysis of the China IUCD Market with respect to the current market size and future prospective.
    • To provide country level analysis of the China IUCD Market for segments by diagnosis and by end users and its sub-segments.
    • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.
    • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the China IUCD market. 
    • SMB Corporation Of India
    • Bayer HealthCare Pharmaceuticals Inc. (US) 
    • Mona Lisa (Belgium)
    • Teva Women’s Health 
    • DKT International (US)

    China IUCD Market Regional Analysis

    • Healthcare IT companies
    • Healthcare companies
    • Contract Research Organizations (CROs)
    • Research and Development (R&D) Companies
    • Academic Medical Institutes and Universities

    Report Scope

    Attribute/Metric Details
    Market Size 2023 13.05 (USD Billion)
    Market Size 2024 13.74 (USD Billion)
    Market Size 2032 24.31 (USD Billion)
    Compound Annual Growth Rate (CAGR) 10.45 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
    Geographies Covered North China, Northeast China, East China, South Central China, Southwest China and Northwest China
    Key Vendors SMB Corporation Of India,Bayer HealthCare Pharmaceuticals Inc. (US), Mona Lisa (Belgium), Teva Women’s Health, DKT International (US)

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment
    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Customer Stories

    “This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

    Noah Malgeri Co-Founder
    Case Study
    Chemicals and Materials